Company intelligence / Profile preview

Shanghai Ruizhi Chemical Research

Shanghai, Shanghai Municipality, Chinascience.org ↗

Ownership: Private
Employees: ~280
Development stage: Preclinical

Overview

No evidence that this entity develops its own therapeutics or has an internal pipeline. The business is focused on R&D and production of fine chemicals and pharmaceutical intermediates.

Modalities: Small moleculePharmaceutical intermediateFine chemical
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

XT17

Pre-clinical

Indications: Bacterial infections, Corneal infections

Beyond the preview

Go deeper on Shanghai Ruizhi Chemical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Ruizhi Chemical Research.

Explore the full profile